FOLD AMICUS THERAPEUTICS INC

Ownership history in ALGERT GLOBAL LLC  ·  20 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.39% (2020 Q2)
Avg. % of fund
0.15%
First filed
2020 Q1
Last filed
2025 Q3
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 537,433 -816,065 -60.3% 0.07% $4.2M $7.88
2025 Q2 ADDED 1,353,498 +533,472 +65.1% 0.16% $7.8M $5.73
2025 Q1 ADDED 820,026 +394,943 +92.9% 0.17% $6.7M $8.16
2024 Q4 ADDED 425,083 +165,923 +64.0% 0.09% $4.0M $9.42
2024 Q3 ADDED 259,160 +170,575 +192.6% 0.07% $2.8M $10.68
2024 Q2 REDUCED 88,585 -95,955 -52.0% 0.03% $879K $9.92
2023 Q4 REDUCED 184,540 -145,885 -44.2% 0.11% $2.6M $14.19
2023 Q1 ADDED 330,425 +52,073 +18.7% 0.17% $3.7M $11.09
2022 Q4 ADDED 278,352 +62,440 +28.9% 0.19% $3.4M $12.21
2022 Q3 ADDED 215,912 +164,364 +318.9% 0.14% $2.3M $10.44
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FOLD price (monthly, adj. close)
← Back to ALGERT GLOBAL LLC Holdings